Index

• AvenCell gets $112M to build switchable CAR-T therapies for ‘the last frontier’ of blood cancers
• Centivo Brings its Curated Health Plan to St. Louis Through New Collaboration with Mercy
• Adcentrx Therapeutics Announces FDA Clearance of Investigational New Drug Application for ADRX-0405, a Potential First-in-Class ADC Targeting STEAP1 for the Treatment of Advanced Solid Tumors
• Madaket Health Selected by NextGen Healthcare to Facilitate Payer Enrollment Process
• Why This Founder Started a Benefits Platform Designed to Make Fertility Care Easier
• CEO Roundtable on Cancer & Paradigm Health Partner to Launch PACT Collective to Expand Clinical Trial Access & Diversity
• Arbital Health and Quartet Health Partner to Expand Severe Mental Illness Value-Based Care Arrangements
• Pre-eclampsia: The deadly mystery scientists can’t solve
• 1upHealth Launches 1up Patient Connect Product Update to Enhance Patient Data Interoperability Across the Industry
• Genomics releases new research showing significant link between genetic risk and obesity
• Exclusive: British startup raises $16M to find genes that rewind the epigenetic clock
• Novonesis and Benchling Forge Long-Term Partnership to Power R&D Innovation
• Launching Reach to Enhance Online Presence, Drive Appointments and Patient Acquisition
• They cracked the code for proteins’ amazing structures
• SPRY Therapeutics Secures $15 Million in Funding Led by Flourish Ventures and Others
• The 2024 PharmaVoice 100
• Astellas and AviadoBio Announce Exclusive Option and License Agreement for Gene Therapy AVB-101 Targeting Frontotemporal Dementia and Other Indications
• Special report 2024: Meet 20 women breaking new ground in biopharma R&D
• Digital Health Rippl announces $23M series A to expand virtual dementia care
• Owkin Announces Partnership with AstraZeneca to Develop an AI gBRCA Pre-Screen Solution for Breast Cancer
• Amneal and Metsera Announce Strategic Collaboration to Develop and Supply Portfolio of Next-Generation Medicines for Obesity and Metabolic Diseases
• Genomics plc Announces David Thornton as President
• Capital Rx’s JUDI® Earns HITRUST i1 Certification
• New Report Reveals Millennial Workers are More Informed Than Ever About Menopause’s Impact on Their Careers — and They’re Ready to Take Action
• TraceLink Propels Organizations Toward DSCSA Compliance Ahead of the November 2024 Deadline
• Endpoints 11 winner Metsera: Clive Meanwell wagers on obesity after Medicines Company success
• Endpoints 11 winner Xaira Therapeutics: Biotech’s largest AI bet with A-list backers
• Stride Publishes Study Revealing Financial Challenges Faced by Millions of Independent Workers
• Embark Launches New Line of Dog Supplements In Next Stage of Pet Care Transformation
• Alight expands Partner Network with the additions of Journey and Carrot Fertility
• Health plan startup Centivo raises $75M
• TraceLink Releases Opus Reports and Dashboards, the First End-User Reporting and Dashboarding Capability Purpose-Built to Gain Real-Time Visibility and Insights from Supply Networks
• Florida Cancer Specialists & Research Institute Contributing to Transformative Cancer Therapies Worldwide
• Sheba Medical Center, ARC Innovation, and Paradigm Health Inc. Forge Strategic Partnership to Expand and Optimize Global Clinical Trials
• Adcentrx Therapeutics Announces Formation of Scientific Advisory Board
• Doceree launches first-ever HCP-only Data Marketplace at DPE 2024
• TraceLink’s Opus Link Actions Minimize Cost and Time to Integrate Enterprise System APIs with Your End-to-End Digitalization Strategy
• RIGImmune Announces Multiple Oral Presentations for Intranasal RIG-101 at European Respiratory Society Congress 2024
• Fierce 50 of 2024
• Carrot Fertility launches CarrotMatch for maternity, the first pregnancy navigation system to match members with the highest quality and most cost-effective providers for their unique needs
• Doceree receives HIPAA certification; reinforces commitment to patient privacy
• These are the 22 most promising healthcare AI startups of 2024, according to top VCs
• TraceLink’s Magnum Release of its Opus Platform Will Revolutionize Supply Chain Management by Enabling All Businesses to Digitalize their End-to-End Supply Networks
• Florida Cancer Specialists & Research Institute Launches Partnership with Paradigm Health, Inc. to Expand Patient Access to Lifesaving Clinical Trials
• Digital Health Awards 2024: Quarterfinalists
• Tech company Fujitsu partners with Paradigm Health to boost clinical trials in Japan
• Capital Rx Launches Never Move Again™, Enabling Self-Funded Plan Sponsors to Perpetually Access the Best Drug Prices Without Ever Having to Reimplement a Plan, Reissue Cards, or Expose Members to Unnecessary Disruption
• TraceLink Launches Program to Enable Solution Partners and Integrators to Digitalize End-to-End Supply Chains
• Avalyn Announces Upcoming Presentations on its Lead Program AP01, Inhaled Pirfenidone, for the Treatment of Pulmonary Fibrosis at the European Respiratory Society International Congress 2024
• TraceLink Becomes First Solution Provider to Secure All 16 GS1 US Conformance Trustmarks for EPCIS File Support
• Bicara and Zenas file for IPOs to push late-phase prospects toward finish line
• After Surviving Anorexia, This Founder Raised $110 Million To Treat The Deadly Disease Online
• Forbes Next Billion-Dollar Startups 2024: Equip
• Yale Spinout in Quantum Field Draws US Intelligence Agency Money
• Many working Americans want children later in life. Fertility startups are making their dreams more possible.
• DNAnexus and Galatea Bio Launch Collaboration to Enhance Precision Medicine with Advanced Genetic Tools for Underserved Populations
• Forbes Cloud 100 2024 List: Plaid & Benchling
• Japanese government grants Shinobi $59M for cell therapy development
• Fierce Biotech’s 2024 Fierce 15: NodThera
• 1upHealth Launches Customer Advisory Board to Advance Industry-Wide Interoperability and Fuel Technological Innovation
• TraceLink and Tecsys Collaboration Brings Advanced Supply Chain Management to Health Systems
• Adaptimmune Receives U.S. FDA Accelerated Approval of TECELRA® (afamitresgene autoleucel), the First Approved Engineered Cell Therapy for a Solid Tumor
• taiba Make Strategic Investment in Immuneel Therapeutics to advance CAR T-cell Research and Make Therapies More Affordable
• Multispecialty Medical Group Sound Physicians Selects AmplifyMD to Support its TeleHospitalist Programs
• Highlands and Paradigm improve access to cancer care options in northwest Arkansas, increasing clinical trial participation by 45%
• Balancing Act: How Do Investors Weigh Founders Versus Markets in Medtech and Healthtech Venture?
• Capital Rx Receives a US Utility Patent Covering its Enterprise Health Platform – JUDI®
• Protenus Granted Seventh Patent for Drug Diversion Surveillance Technology
• HiLabs’ AI discovers incorrect physician data as an industry-wide pervasive problem
• Invetx Announces Upcoming Acquisition by Dechra Pharmaceuticals, Global Leader in Animal Health
• Sifted Drug Discovery (Q3 2024) – 20 Startups to Watch
• Genomics plc Announces New Extension and Expansion of Drug Discovery Collaboration with Vertex
• XO Health Powers Provider Search and Improved Transparency with Kyruus Health
• Nocion Therapeutics Presents Data on Preclinical and Clinical Development of Taplucainium, a Novel, Charged Sodium Channel Blocker, as a potential treatment for Chronic Cough at the 13th London International Cough Symposium
• Breaking the Cycle of Inflammation in Parkinson’s Disease
• Firefly Health Expands the Firefly Nearby Network, Enhancing the Bridge Between Virtual and In-Person Patient Care
• 1upHealth Achieves HITRUST Implemented, 1-year (i1) Certification to Manage Data Protection and Mitigate Cybersecurity Threats
• Notable Achieves Oracle Validated Integration with Oracle Health Expertise for Delivering Proven, Repeatable Integration
• Immuneel Therapeutics Raises INR 100 Cr to Expand Cancer Therapy Innovations
• Nocion Therapeutics Appoints Dr. Catherine Bonuccelli to Scientific Advisory Board and Joan Shaw to Senior Vice President, Clinical Operations
• WelbeHealth Continues California Expansion with Opening of New PACE Centers in Riverside and Coachella Valley
• Top Boston Startups to Watch in 2024: Zus Health & Vendr
• Owkin, an AI-Biotech Unicorn, Brings Its Cutting-Edge AI to Germany, Austria and Switzerland to Accelerate Research
• Digital health Q1 funding coasting at $1B as telehealth and digital therapeutics lose ground
• ASPIRE-FTD Phase 1/2 Clinical Trial Opens in the U.S. at The Ohio State University Wexner Medical Center
• RareCyte secures $20M financing to expand the Orion™ Spatial Biology platform including Multiplex Assay Reagents, Software and Precision Biology Services
• HiLabs Study Featured in MedPAC June 2024 Report to Congress Highlights Alarming Inconsistencies in Provider Directories
• Bicara Therapeutics Reports Updated Interim Phase 1/1b Data of Ficerafusp Alfa (BCA101) in 1L HPV-negative Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
• Healthcare startup Doceree raises $13.6 million in funding from Creaegis
• Curie.Bio Raises $380M Pro Rata Series A Fund To Support Portfolio Companies Through Clinical Trials